23 mai
12:00 |

The Impact of Demographic Changes on Blood Donation and Transfusion Demand, Implications of a Population Based Longitudinal Study

Special guest speaker Dr. Andreas Greinacher University Hospital Greifswald, Germany Head of the Institute of Immunology and Transfusion Medicine Objectives 1. To understand the association between demographic changes and blood donation numbers To become aware that the baby boom generation who is

21 Aoû
8:30 | Toronto

6th Annual SCAGO Sickle Cell Summit

The Sickle Cell Awareness Group of Ontario (SCAGO) invites you to participate in the SCAGO Sickle Cell Summit 2026, a two-day, in-person gathering focused on improving outcomes and lived experiences for individuals and families affected by sickle cell disease (SCD) across Canada. This year's summit

29 juin
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

8 juin
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

1 juin
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

11 mai
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

4 mai
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

20 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

13 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

6 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des